Acupuncture for vulvodynia
Powell et al. · Journal of the Royal Society of Medicine · 1999
OBJECTIVE
Evaluate the efficacy of acupuncture in the treatment of vulvodynia (vulvar pain and burning without an identifiable cause)
WHO
12 women aged 18 to 68 years with vulvodynia refractory to conventional treatments
DURATION
10 weeks of follow-up, with 5 weeks of treatment per patient
POINTS
4 points: spleen meridian 6 and 9, liver meridian 3, large intestine 4
🔬 Study Design
Group 1
n=6
Acupuncture during the first 5 weeks
Group 2
n=6
Acupuncture during the last 5 weeks
📊 Results in numbers
Patients who considered themselves 'cured'
Symptom improvement
Mild improvement
No response
Percentage highlights
📊 Outcome Comparison
Treatment response
This study showed that acupuncture can help women with vulvodynia (pain and burning in the genital region) when other treatments have failed. About 75% of patients had some degree of improvement, with two considering themselves completely cured.
Article summary
Plain-language narrative summary
Vulvodynia is a syndrome characterized by vulvar pain and burning sensation without abnormal clinical findings, which significantly affects women's quality of life and sexual function. This pioneering 1999 study, published in the Journal of the Royal Society of Medicine, investigated the use of acupuncture as a therapeutic alternative for this challenging condition. The research was conducted by Powell and Wojnarowska in Oxford, England, involving 12 women aged 18 to 68 years who suffered from vulvodynia refractory to conventional treatments. All participants had tried multiple therapies without success, including low-dose amitriptyline, emollients, topical steroids, antihistamines, and other interventions listed as standard treatments.
The study was a crossover design, in which each patient served as her own control. Six patients received acupuncture during the first five weeks and the other six during the last five weeks of the ten-week period. The acupuncture protocol involved insertion of four fine needles at specific points: two on the spleen meridian (points 6 and 9), one on the liver meridian (point 3), and one on the large intestine meridian (point 4). Interestingly, the authors found that these points had been recommended for external genital pain in the Yellow Emperor's Classic of Internal Medicine centuries ago.
Outcomes were monitored weekly through questionnaires, a visual analog scale for pain, and an adapted quality-of-life questionnaire. Side effects were minimal, limited to minor bleeding or local discomfort at the needle site. The results revealed three distinct response patterns. Two patients (17%) considered themselves 'cured' and were satisfied to be discharged from the clinic.
One of them, notably, had been unable to tolerate amitriptyline because of side effects. Three patients (25%) experienced symptom control during the acupuncture period but relapsed after treatment cessation, wishing to continue with acupuncture. Four patients (33%) judged acupuncture possibly more effective than previous treatments, although their scores did not change substantially. Three patients (25%) felt no improvement at all.
The authors discuss that vulvodynia is commonly associated with other conditions such as interstitial cystitis, irritable bowel syndrome, and myalgic encephalomyelitis. They propose that the condition represents an atypical pain syndrome, in which pain is felt in the absence of the usual nociceptor stimulus. The proposed mechanism involves sensitization of dorsal horn neurons, which respond abnormally to light touch and pressure. Acupuncture is hypothesized to raise beta-endorphin levels and desensitize the dorsal horn, potentially 'switching off' the hyperactive and dysfunctional sensory pain system.
The clinical implications are significant, considering the refractory nature of vulvodynia to conventional treatments. The study suggests that acupuncture may be a valuable option for patients who do not respond to other therapies. However, the authors acknowledge that acupuncture is time-consuming and that much of the beneficial effect may derive from regular specialized contact. The fact that even non-responders showed slight improvement on post-treatment questionnaires suggests an important component of specialized care and attention.
Strengths
- 1First study to investigate acupuncture for vulvodynia
- 2Use of points based on ancient traditional Chinese medicine
- 3Crossover design allowing internal control
- 4Systematic monitoring with validated instruments
Limitations
- 1Very small sample size (n=12)
- 2Lack of a true placebo control group
- 3Possible gratitude bias in the results
- 4Lack of long-term follow-up
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
Refractory vulvodynia represents one of the most frustrating scenarios in chronic pelvic pain practice — patients who go through dermatologists, gynecologists, and general practitioners without resolution, accumulating failed trials with amitriptyline, topical corticosteroids, and antihistamines. This work by Powell and Wojnarowska, although pioneering and modest in size, formally opens the discussion about acupuncture as a therapeutic resource in this population. Vulvodynia shares pathophysiology with other central sensitization syndromes — interstitial cystitis, irritable bowel syndrome — and it is precisely in this profile of pain without an identifiable nociceptor substrate that acupuncture has its most convincing mechanism of action. Women with refractory disease, drug intolerance, or multiple failed therapeutic attempts are the natural candidates for this integrative approach, especially when the goal is to modulate dorsal horn sensitization through non-pharmacological pathways.
▸ Notable Findings
The most striking finding is not the 17% 'cure' rate but the response pattern across the spectrum: approximately 75% of participants reported some degree of perceived benefit, distributed among complete remission, symptom control dependent on maintenance, and subjective improvement without correlate on the scales. The subgroup that relapsed after discontinuation but wished to continue treatment is clinically informative — it suggests that acupuncture acts as a sustained modulator and not as an inducer of permanent remission in some cases, which directly guides the design of maintenance protocols. The choice of points also deserves attention: SP-6, SP-9, LR-3, and LI-4 — a combination that converges hepatic harmonization, spleen meridian regulation, and systemic analgesia, documented in the Huangdi Neijing for external genital pain. The fact that this classical indication preceded the Western recognition of the syndrome by centuries lends historical consistency to the protocol.
▸ From My Experience
In my practice with chronic female pelvic pain, vulvodynia and vestibular vulvitis are conditions that arrive at the Pain Center already with extensive therapeutic histories, and acupuncture is usually introduced as part of a multimodal program — not in isolation. I have observed perceptible initial response between the third and fifth sessions, generally reported as reduction of allodynia to touch and improvement in everyday discomfort before any impact on sexual activity. I typically work with cycles of eight to ten weekly sessions for response assessment, keeping SP-6, LR-3, and LI-4 as a base and adjusting according to the traditional Chinese medicine pattern — especially when there is a Liver Qi stagnation component associated with chronic emotional tension. I usually combine pelvic floor biofeedback and, when available, specialized pelvic physical therapy. Patients with documented drug intolerance, such as the one described in the article, respond particularly well because they arrive without the confounder of adverse effects and with high motivation. Profiles with an associated anxious-depressive component usually require monthly maintenance sessions for an extended period.
Indexed scientific article
This study is indexed in an international scientific database. Check your institutional access to obtain the full article.
Scientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories